Ginkgo Bioworks (DNA) completed the first milestone of a partnership with Merck (MRK) focused on improving biologic manufacturing. As part of this milestone completion, Ginkgo will receive a research milestone payment of $9M in cash. The two companies will now move on to the second stage of this partnership, which will be focused on continuing to improve the production process.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks